bf/NASDAQ:HTGM_icon.jpeg

NASDAQ:HTGM

HTG Molecular Diagnostics, Inc.

  • Stock

USD

Last Close

0.48

14/06 20:00

Market Cap

1.06M

Beta: 0.99

Volume Today

725.43K

Avg: 214.85K

PE Ratio

−0.05

PFCF: −0.06

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
433.64K
-
1.11M
155.90%
1.84M
65.65%
1.86M
0.97%
1.35M
27.50%
1.24M
7.60%
1.29M
3.58%
1.38M
7.20%
1.74M
26.00%
1.45M
16.75%
average payables
676.79K
-
849.33K
25.49%
836.62K
1.50%
743.23K
11.16%
1.60M
115.31%
2.14M
34.00%
1.76M
18.10%
1.51M
14.27%
1.50M
0.44%
1.40M
6.38%
average receivables
393.79K
-
702.49K
78.39%
758.69K
8.00%
1.05M
37.98%
3.87M
269.38%
5.68M
47.01%
4.09M
28.08%
2.38M
41.87%
1.84M
22.55%
1.76M
4.54%
book value per share
-84.16
-
-90.13
7.09%
4.67
105.19%
-0.98
121.03%
-0.36
63.28%
0.96
365.43%
113.24
11,721.99%
37.56
66.83%
17.99
52.09%
6.06
66.30%
capex per share
-2.92
-
-3.22
10.27%
-0.37
88.49%
-0.34
7.59%
-0.12
64.81%
-0.04
64.18%
-5.21
11,986.25%
-1.18
77.44%
-1.11
5.21%
-0.03
97.68%
capex to depreciation
-2.47
-
-1.73
30.03%
-2.02
16.94%
-1.32
34.60%
-0.82
37.78%
-0.65
21.30%
-0.64
1.73%
-0.34
47.00%
-0.89
165.25%
-0.04
95.61%
capex to operating cash flow
0.07
-
0.07
0.32%
0.07
5.37%
0.09
25.90%
0.06
29.66%
0.07
17.04%
0.07
8.33%
0.03
57.87%
0.04
40.21%
0.00
96.79%
capex to revenue
-0.35
-
-0.26
25.70%
-0.33
28.51%
-0.38
14.54%
-0.07
81.77%
-0.04
36.14%
-0.06
30.10%
-0.05
7.64%
-0.07
36.36%
-0.00
95.00%
cash per share
6.81
-
13.55
99.05%
8.71
35.69%
2.08
76.18%
1.18
43.36%
1.41
20.17%
156.05
10,943.46%
74.41
52.32%
37.96
48.98%
13.73
63.83%
days of inventory on hand
120.89
-
168.01
38.98%
240.89
43.38%
133.35
44.64%
86.67
35.01%
93.69
8.10%
52.00
44.49%
136.45
162.37%
177.18
29.85%
72.59
59.03%
days payables outstanding
121.87
-
108.01
11.37%
79.31
26.57%
67.22
15.25%
179.04
166.36%
132.64
25.91%
68.10
48.66%
123.34
81.12%
147.02
19.20%
92.40
37.15%
days sales outstanding
98.26
-
87.84
10.61%
64.69
26.36%
97.95
51.43%
157.19
60.47%
85.08
45.87%
60.14
29.32%
67.83
12.79%
85.75
26.41%
81.51
4.94%
debt to assets
0.01
-
1.29
12,747.74%
0.28
78.66%
0.64
132.08%
0.41
35.48%
0.22
46.31%
0.25
12.81%
0.36
44.02%
0.38
7.01%
0.27
29.27%
debt to equity
-0.00
-
-0.47
23,710.00%
0.64
237.24%
-2.11
427.94%
-2.86
35.86%
0.46
116.04%
0.47
2.32%
0.87
85.92%
1.13
28.98%
0.90
20.37%
dividend yield
earnings yield
-0.02
-
-0.02
18.60%
-0.01
64.28%
-0.01
50.47%
-0.01
46.07%
-0.00
73.30%
-0.72
44,051.14%
-0.94
30.47%
-0.46
51.56%
-6.09
1,234.46%
enterprise value
659.33M
-
668.74M
1.43%
2.84B
325.35%
2.30B
19.19%
3.10B
34.71%
10.09B
225.87%
30.38M
99.70%
12.41M
59.13%
39.70M
219.82%
-3.83M
109.64%
enterprise value over ebitda
-58.65
-
-52.43
10.60%
-149.66
185.46%
-101.32
32.30%
-188.73
86.28%
-716.66
279.73%
-1.83
99.74%
-0.69
62.23%
-2.03
193.70%
0.19
109.37%
ev to operating cash flow
-55.77
-
-51.45
7.73%
-147.82
187.27%
-103.38
30.06%
-186.85
80.74%
-765.98
309.93%
-1.82
99.76%
-0.76
58.12%
-2.41
215.63%
0.21
108.65%
ev to sales
293.94
-
200.89
31.66%
703.80
250.35%
447.85
36.37%
209.80
53.15%
469.26
123.67%
1.58
99.66%
1.45
8.20%
4.46
206.97%
-0.60
113.49%
free cash flow per share
-47.24
-
-51.94
9.95%
-5.69
89.04%
-4.25
25.37%
-2.08
51.17%
-0.64
69.09%
-84.09
13,010.10%
-43.42
48.36%
-29.68
31.66%
-20.73
30.16%
free cash flow yield
-0.02
-
-0.02
9.95%
-0.01
65.38%
-0.01
45.27%
-0.01
46.11%
-0.00
75.30%
-0.67
47,342.18%
-0.76
13.50%
-0.46
39.60%
-5.19
1,038.44%
graham net net
-90.75
-
-104.29
14.92%
2.93
102.81%
-1.84
162.72%
-1.06
42.24%
0.58
155.02%
70.34
11,955.44%
25.72
63.43%
7.69
70.10%
1.51
80.32%
graham number
289.07
-
325.77
12.70%
24.95
92.34%
10.06
59.68%
4.26
57.64%
4.01
5.82%
481.98
11,909.83%
213.85
55.63%
109.58
48.76%
57.56
47.48%
income quality
1.00
-
0.93
7.31%
0.90
3.41%
0.85
5.05%
0.87
2.37%
0.80
8.40%
0.87
8.06%
0.78
9.77%
0.96
23.34%
0.85
11.47%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
interest coverage
-56.24
-
-18.18
67.68%
-10.99
39.56%
-13.03
18.60%
-13.55
4.02%
-17.92
32.21%
-19.80
10.51%
-19.11
3.48%
-16.74
12.40%
-24.31
45.21%
interest debt per share
0.96
-
44.83
4,570.76%
3.48
92.24%
2.40
31.03%
1.19
50.51%
0.48
59.51%
57.70
11,906.66%
35.44
38.57%
22.10
37.65%
6.40
71.04%
inventory turnover
3.02
-
2.17
28.05%
1.52
30.25%
2.74
80.64%
4.21
53.87%
3.90
7.49%
7.02
80.15%
2.68
61.89%
2.06
22.99%
5.03
144.07%
invested capital
-0.00
-
-0.47
23,710.00%
0.64
237.24%
-2.11
427.94%
-2.86
35.86%
0.46
116.04%
0.47
2.32%
0.87
85.92%
1.13
28.98%
0.90
20.37%
market cap
661.10M
-
661.10M
0%
2.84B
329.12%
2.29B
19.12%
3.10B
35.02%
10.07B
224.97%
26.74M
99.73%
22.17M
17.11%
37.59M
69.59%
3.55M
90.56%
net current asset value
-23.52M
-
-26.77M
13.81%
12.30M
145.97%
-8.91M
172.43%
-6.37M
28.56%
15.32M
340.63%
20.22M
31.95%
12.16M
39.87%
7.13M
41.39%
3.27M
54.18%
net debt to ebitda
0.16
-
-0.60
480.03%
-0.40
33.60%
-0.19
52.64%
0.07
139.31%
-1.70
2,396.23%
-0.22
87.12%
0.54
348.01%
-0.11
119.86%
0.37
439.61%
net income per share
-44.13
-
-52.33
18.60%
-5.92
88.69%
-4.58
22.70%
-2.24
51.13%
-0.75
66.59%
-91.17
12,100.66%
-54.12
40.64%
-29.66
45.19%
-24.28
18.14%
operating cash flow per share
-44.33
-
-48.73
9.93%
-5.32
89.07%
-3.91
26.60%
-1.95
49.97%
-0.60
69.39%
-78.88
13,083.90%
-42.25
46.44%
-28.56
32.39%
-20.70
27.52%
payables turnover
2.99
-
3.38
12.83%
4.60
36.19%
5.43
18.00%
2.04
62.46%
2.75
34.98%
5.36
94.79%
2.96
44.79%
2.48
16.11%
3.95
59.11%
receivables turnover
3.71
-
4.16
11.87%
5.64
35.79%
3.73
33.96%
2.32
37.68%
4.29
84.75%
6.07
41.48%
5.38
11.34%
4.26
20.89%
4.48
5.20%
research and ddevelopement to revenue
1.87
-
0.92
50.64%
1.14
23.25%
1.54
35.18%
0.68
56.00%
0.59
13.50%
0.55
6.05%
0.71
29.21%
0.68
3.88%
1.07
55.83%
return on tangible assets
-2.68
-
-1.60
40.24%
-0.54
66.08%
-1.41
160.12%
-0.89
36.79%
-0.38
57.86%
-0.43
13.78%
-0.59
38.63%
-0.56
5.07%
-1.21
115.81%
revenue per share
8.41
-
12.48
48.41%
1.12
91.04%
0.90
19.33%
1.74
93.01%
0.98
43.90%
90.73
9,190.09%
22.17
75.57%
15.41
30.48%
7.16
53.54%
roe
0.52
-
0.58
10.75%
-1.27
318.15%
4.66
467.58%
6.20
33.10%
-0.78
112.59%
-0.81
3.20%
-1.44
78.97%
-1.65
14.42%
-4.01
142.94%
roic
0.53
-
1.00
88.89%
-0.68
167.81%
-3.93
477.59%
-3.11
20.90%
-0.53
83.12%
-0.52
1.41%
-0.70
34.29%
-0.76
9.33%
-1.85
143.70%
sales general and administrative to revenue
3.71
-
3.40
8.48%
1.19
65.05%
0.93
21.72%
shareholders equity per share
-84.16
-
-90.13
7.09%
4.67
105.19%
-0.98
121.03%
-0.36
63.28%
0.96
365.43%
113.24
11,721.99%
37.56
66.83%
17.99
52.09%
6.06
66.30%
stock based compensation to revenue
0.04
-
0.06
41.47%
0.10
80.54%
0.20
94.63%
0.10
50.17%
0.09
6.94%
0.06
29.67%
0.21
232.79%
0.15
27.15%
0.13
17.12%
tangible asset value
-22.45M
-
-24.04M
7.09%
16.89M
170.27%
-5.59M
133.11%
-3.06M
45.30%
21.09M
789.39%
23.97M
13.64%
14.48M
39.57%
10.40M
28.20%
5.39M
48.16%
tangible book value per share
-84.16
-
-90.13
7.09%
4.67
105.19%
-0.98
121.03%
-0.36
63.28%
0.96
365.43%
113.24
11,721.99%
37.56
66.83%
17.99
52.09%
6.06
66.30%
working capital
954.37K
-
2.70M
182.77%
28.54M
957.53%
5.11M
82.08%
4.61M
9.91%
30.98M
572.61%
32.47M
4.79%
25.63M
21.05%
17.24M
32.73%
7.38M
57.20%

All numbers in USD (except ratios and percentages)